Dimitri Krainc

Inversor de Capital Privado en OrbiMed Advisors Private Equity .

Health Technology

Finance

Perfil

Dimitri Krainc, M.D., Ph.D., is a Venture Partner with OrbiMed.
Dr. Krainc currently serves as the A.
M.
Ward Professor and Chairman of the Department of Neurology and Director of the Center for Neurogenetics at Northwestern University, Feinberg School of Medicine in Chicago.
Previously, Dr. Krainc spent more than 20 years at Harvard Medical School where he completed his research training followed by a neurology residency and fellowship at Massachusetts General Hospital, serving on the neurology faculty until 2013.
Dr. Krainc is the founder of Lysosomal Therapeutics, Inc. and serves on the SAB of Intellia Therapeutics.
He received several awards for his work, including the Javits Neuroscience Award.

Cargos activos de Dimitri Krainc

Empresas	Cargo	Inicio
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.	Inversor de Capital Privado	-

Todos los cargos activos de Dimitri Krainc

Antiguos cargos conocidos de Dimitri Krainc.

Empresas	Cargo	Fin
Lysosomal Therapeutics, Inc. Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA.	Fundador	-

Ver el detalle de la experiencia de Dimitri Krainc.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Dimitri Krainc.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Lysosomal Therapeutics, Inc. Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA.	Health Technology
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.	Finance